Table 1. Summary of the expression of VGCC in the pseudoglandular human lung.
Epithelium (apical) | Epithelium (basolateral) | Smooth muscle | Blocker | |
Cav1.2 (L-type, A1C) | Y | Y | Y | Nifedipine |
Cav1.3 (L-type, A1D) | Y | N | N | Nifedipine |
Cav2.1 (P/Q-type, A1A) | N | N | Y | Agatoxin |
Cav2.2 (N-type, A1B) | N | N | N | ω-Conotoxin |
Cav2.3 (R-type, A1E) | Y | N | N | SNX-482 |
Cav3.2 (T-type, A1H) | N | Y | Y | None |
Cav3.3 (T-type, A1I) | N | N | N | None |